Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Kim, Donghoon  [Clear All Filters]
Journal Article
Lee S, Kim S, Park YJoo, Yun SPil, Kwon S-H, Kim D, Kim DYeon, Shin JSoo, Cho DJin, Lee GYeal, et al. The c-Abl inhibitor, Radotinib HCl is neuroprotective in a preclinical Parkinson's disease mouse model. Hum Mol Genet. 2018.
Kang I, Yoo JMin, Kim D, Kim J, Cho MKeun, Lee S-E, Kim DJin, Lee B-C, Lee JYoung, Kim J-J, et al. Graphene Quantum Dots Alleviate Impaired Functions in Niemann-Pick Disease Type C in Vivo. Nano Lett. 2021.
Choi S, Kim D, Kam T-I, Yun S, Kim S, Park H, Hwang H, Pletnikova O, Troncoso JC, Dawson VL, et al. Lysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity. PLoS One. 2015;10(12):e0143854.
Li H, Ham A, Ma TChi, Kuo S-H, Kanter E, Kim D, Ko HSeok, Quan Y, Sardi SPablo, Li A, et al. Mitochondrial Dysfunction and Mitophagy Defect Triggered by Heterozygous GBA Mutations. Autophagy. 2018.
Kuo S-H, Tasset I, Cheng MM, Diaz A, Pan M-K, Lieberman OJ, Hutten SJ, Alcalay RN, Kim S, Ximénez-Embún P, et al. Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy. Sci Adv. 2022;8(6):eabm6393.
Jeon H, Jang SYoung, Kwak G, Yi YWeon, You M-H, Park NYoung, Jo JHee, Yang JWon, Jang HJi, Jeong S-Y, et al. TGFβ4 alleviates the phenotype of Charcot-Marie-Tooth disease type 1A. Brain. 2023.
Seo BAm, Kim D, Hwang H, Kim MSeong, Ma S-X, Kwon S-H, Kweon SHo, Wang H, Yoo JMin, Choi S, et al. TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. Neuron. 2021.